Latest News- Heparin Market: Low Molecular Weight Heparin is expected to lead the Product segment during 2024-2028

The Heparin Market is being driven by Increasing prevalence of coagulation disorders

The Heparin Market is expected to grow at a CAGR of 7.22% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 3.34 billion. Heparin, discovered in 1961, revolutionized anticoagulant therapy and became a cornerstone in treating hemostasis and thrombosis. Its impact on the healthcare sector is significant, with extensive scientific research and observations shaping our understanding of bleeding and thrombotic disorders. Notably, fractionated heparin's introduction led to the development of low-molecular-weight heparin, transforming the clinical management of surgical and medical thrombosis. These advancements have shaped the global healthcare landscape, enhancing patient care and outcomes. 

Get more information on Heparin Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Low Molecular Weight Heparin
  • Ultra-Low Molecular Weight Heparin
  • Unfractionated Heparin
• Route Of Administration
  • Subcutaneous injection
  • Intravenous infusion
• Source
  • Bovine
  • Porcine
• Application
  • Venous Thromboembolism
  • Atrial Fibrillation
  • Renal Impairment
  • Coronary Artery Disease
  • Stroke
  • Surgical Procedures
  • Others
• End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare
• Geography
  • Europe
    • France
    • Germany
    • Italy
  • North America
    • US
  • Asia
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of coagulation disorders
• Growing prevalence of chronic conditions
• Reintroduction of alternative sources to produce heparin

However, the market also witnesses some limitations, which are as follows:

• Side effects of heparin
• Increase in shortage of raw heparin
• Product recalls

Benefits of Buying Global Heparin Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Heparin Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Heparin Market encompasses various applications including blood product safety, heart rhythm management, and atrial fibrillation treatment. Elderly healthcare, diabetes management, and cancer treatment are key areas of focus. Dosage optimization and drug approval processes are crucial for heparin therapy. Plasma fractionation and medical device innovation are driving market growth. The regulatory landscape and medical device safety are paramount in ensuring quality control. Preventive healthcare, chronic disease management, and patient safety initiatives are essential in the aging population's health. Anticoagulation therapy, drug pricing, and healthcare access are significant challenges. Adverse drug events, drug launches, and thinner medications require constant monitoring. Lifestyle modifications, healthcare policy, and health education are vital in noncommunicable disease prevention. Medical negligence and healthcare litigation are potential risks. The market analysis includes plasma protein therapy, donation awareness, donation drives, and bioengineered heparin manufacturing. Medical device innovation, regulatory landscape, and healthcare policy shape the market's future.

Market Research Overview

The global heparin market, a segment of the larger pharmaceuticals industry within the healthcare sector, experienced significant growth in 2023, valued at USD1.495.51 billion. This market expansion can be attributed to the increasing demand for blood thinners in thrombosis prevention, particularly in the context of pulmonary embolism (PE) and stroke prevention. The pharmaceuticals market, encompassing entities involved in research and development (R&D) or production of various drugs, including non-generic, generic, and veterinary, was the driving force behind this figure. The market's growth is fueled by factors such as an aging population, with the global population aged 60 and above predicted to increase significantly, leading to a higher prevalence of conditions requiring thrombosis prevention.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/